Azar WJ - Search Results

1

IGFBP-2: The dark horse in metabolism and cancer.

Russo VC, Azar WJ, Yau SW, Sabin MA, Werther GA. Russo VC, et al. Among authors: azar wj. Cytokine Growth Factor Rev. 2015 Jun;26(3):329-46. doi: 10.1016/j.cytogfr.2014.12.001. Epub 2014 Dec 18. Cytokine Growth Factor Rev. 2015. PMID: 25544066 Review.

2

IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells.

Azar WJ, Zivkovic S, Werther GA, Russo VC. Azar WJ, et al. Oncogene. 2014 Jan 30;33(5):578-88. doi: 10.1038/onc.2012.630. Epub 2013 Feb 25. Oncogene. 2014. PMID: 23435424

3

IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells.

Azar WJ, Azar SH, Higgins S, Hu JF, Hoffman AR, Newgreen DF, Werther GA, Russo VC. Azar WJ, et al. Among authors: azar sh. Endocrinology. 2011 Sep;152(9):3332-42. doi: 10.1210/en.2011-1121. Epub 2011 Jul 12. Endocrinology. 2011. PMID: 21750048

4

IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity.

Sabin MA, Russo VC, Azar WJ, Yau SW, Kiess W, Werther GA. Sabin MA, et al. Among authors: azar wj. Pediatr Endocrinol Rev. 2011 Jun;8(4):382-93. Pediatr Endocrinol Rev. 2011. PMID: 21972778 Review.

5

IGFBP-2 - taking the lead in growth, metabolism and cancer.

Yau SW, Azar WJ, Sabin MA, Werther GA, Russo VC. Yau SW, et al. Among authors: azar wj. J Cell Commun Signal. 2015 Jun;9(2):125-42. doi: 10.1007/s12079-015-0261-2. Epub 2015 Jan 25. J Cell Commun Signal. 2015. PMID: 25617050 Free PMC article.

6

Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia.

Bajpai A, Simm PJ, McPherson SJ, Russo VC, Azar WJ, Wark JD, Risbridger GP, Werther GA. Bajpai A, et al. Among authors: azar wj. J Endocrinol. 2010 Oct;207(1):27-34. doi: 10.1677/JOE-10-0006. Epub 2010 Jul 30. J Endocrinol. 2010. PMID: 20675302

7

APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.

Liu DS, Read M, Cullinane C, Azar WJ, Fennell CM, Montgomery KG, Haupt S, Haupt Y, Wiman KG, Duong CP, Clemons NJ, Phillips WA. Liu DS, et al. Among authors: azar wj. Gut. 2015 Oct;64(10):1506-16. doi: 10.1136/gutjnl-2015-309770. Epub 2015 Jul 17. Gut. 2015. PMID: 26187504

8

Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer.

Azar WJ, Christie EL, Mitchell C, Liu DS, Au-Yeung G, Bowtell DDL. Azar WJ, et al. Cancer Res. 2020 Nov 15;80(22):4960-4971. doi: 10.1158/0008-5472.CAN-19-3044. Epub 2020 Sep 11. Cancer Res. 2020. PMID: 32917727

9

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition.

Au-Yeung G, Lang F, Azar WJ, Mitchell C, Jarman KE, Lackovic K, Aziz D, Cullinane C, Pearson RB, Mileshkin L, Rischin D, Karst AM, Drapkin R, Etemadmoghadam D, Bowtell DD. Au-Yeung G, et al. Among authors: azar wj. Clin Cancer Res. 2017 Apr 1;23(7):1862-1874. doi: 10.1158/1078-0432.CCR-16-0620. Epub 2016 Sep 23. Clin Cancer Res. 2017. PMID: 27663592 Free PMC article.

10

Inhibiting the system x_C^-/glutathione axis selectively targets cancers with mutant-p53 accumulation.

Liu DS, Duong CP, Haupt S, Montgomery KG, House CM, Azar WJ, Pearson HB, Fisher OM, Read M, Guerra GR, Haupt Y, Cullinane C, Wiman KG, Abrahmsen L, Phillips WA, Clemons NJ. Liu DS, et al. Among authors: azar wj. Nat Commun. 2017 Mar 28;8:14844. doi: 10.1038/ncomms14844. Nat Commun. 2017. PMID: 28348409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters